Home › Psoriatic Arthritis › District of Columbia › Washington
Psoriatic Arthritis clinical trials in Washington, DC
3 studies for Psoriatic Arthritis are looking for participants at sites in and around Washington (within about 30 miles). Open a study to see who can join and how to contact the study team.
Recruiting for a study here? Feature it at the top of this page — $99 for 30 days →
Testing an Immunotherapy Anti-cancer Drug, Nivolumab, for Advanced Cancers in Patients With Autoimmune Disorders, AIM-NIVO
RecruitingPhase 1
- MedStar Georgetown University Hospital, Washington D.C.
- National Cancer Institute Developmental Therapeutics Clinic, Bethesda · 7 mi away
A Study to Assess Adverse Events, Change in Disease Activity, and How the Drug Moves Through the Body in Children With Juvenile Psoriatic Arthritis (jPsA) Receiving Subcutaneously Injected Risankizumab or Adalimumab
RecruitingPhase 3
- Childrens National Medical Center /ID# 259284, Washington D.C.
Observational Study of Pediatric Rheumatic Diseases: The CARRA Registry
RecruitingObservational study
- Childrens National Medical Center, Washington D.C.
About Psoriatic Arthritis
Psoriasis is a skin disease that causes itchy or sore patches of thick, red skin with silvery scales. Find out about symptoms and treatment.
More about Psoriatic Arthritis on MedlinePlus
Psoriatic Arthritis trials in other cities
- Houston, TX8 studies
- Charlotte, NC7 studies
- Altoona, PA6 studies
- Parma, OH6 studies
- Tampa, FL6 studies
- Philadelphia, PA6 studies
- Plantation, FL5 studies
- Cleveland, OH5 studies
- Clearwater, FL5 studies
- New York City, NY5 studies
- Milwaukee, WI5 studies
- San Diego, CA5 studies
Other studies in Washington
- Cancer (all types)58 studies
- Non-Small Cell Lung Cancer55 studies
- Breast Cancer46 studies
- Metastatic Cancer43 studies
- Lung Cancer41 studies
- Prostate Cancer38 studies
- Obesity33 studies
- Colorectal Cancer29 studies
- Cardiovascular Disease28 studies
- Bladder Cancer26 studies
- Acute Myeloid Leukemia24 studies
- Ovarian Cancer23 studies
From ClinicalTrials.gov, data retrieved Oct 6, 2026. Each study sets its own eligibility; the study team decides who can join.